Showing:
◈ medicine×
NO to Death by Brexit
24/06/2019
We are protesting against the fact that due to Brexit people with life threatening diseases are not guaranteed their vital medicines. The clock is ticking without any assurances that the UK is prepared for the crash out of the EU whch has a terrible effect on people’s lives.
The Brexit Benefit Myths
29/10/2021
The government and its supporters are beginning to claim 'benefits' of being outside the European Union some of which were always available to EU member states or, in other cases, are not benefits at all.
The chief pharmaceutical officer has warned that without mitigation, the supply of medicines and medical devices into Northern Ireland would be considered a "very high risk area".
The BMA has published a series of briefings, which outline our policy positions on a range of key issues relating to the impact of Brexit on the UK healthcare system.
Why would anyone trust Brexit Britain again?
24/07/2021
Just seven months after singing its praises, British Prime Minister Boris Johnson is attempting to rewrite the Brexit deal he signed with the European Union.
Informa Pharma Intelligence (IPI) has found that some drug firms may withdraw up to 90% of their products from Northern Ireland, once the Brexit grace period has passed.
Hundreds of researchers and organisations across Europe have called for the rapid association of the UK and Switzerland to Horizon Europe.
As the possibility of a no-deal Brexit scenario increases, and the government publishes its “no-deal preparedness” notices, it is worth taking stock of the sheer variety of problems that would arise with a no-deal Brexit – and the devastating consequences that would arise from such a legal limbo. Here’s what we know so far.
US Pharma industry lobby telling US trade negotiators that US-UK trade deal is “an important opportunity” to deal with “artificially depressed prices” in UK [1 min]
03/12/2019
This video from January is US Pharma industry lobby telling US trade negotiators that US-UK trade deal is “an important opportunity” to deal with “artificially depressed prices” in UK - “dictated” via our “primary payer” system
Brussels ready to slap tariffs and quotas on UK exports – and even to ‘suspend cooperation in certain sectors’
An island nation must trade with its nearest mainland, whatever our new Brexit opportunities minister claims.
A review of evidence about opportunities, challenges and risks to the North East economy and its key sectors with recommendations for action.
Delays caused by added bureaucracy following Brexit and other international situations such as the war in Ukraine are leading to shortage of medicines, with pharmacies scrambling to offer replacements so as not to keep their clients without the items they need.
No-deal Brexit: 10 ways it could affect you
01/08/2019
How could you be affected if the UK does leave the EU without an agreement?
NHS costs, food standards and intellectual property rights must be protected in any deal by the UK to join a major international trade agreement, a Lords committee has told ministers in a new report.
How will NICE fare in a post-Brexit world?
17/05/2021
NICE has a global reputation as a pioneering HTA – but is that influence at risk now that the UK has left the EU? Experts from ICON give us their views on the past, present and future of NICE’s standing on the world stage.
The well known logistics company, chaired by German billionaire Klaus-Michael Kühne, has been tasked with delivering “medicines and medical goods which are at risk of shortage” into the UK “within days”.
The Brexit predictions that came true, those that didn’t—and what we didn’t see coming - BMJ
03/08/2022
Six years after the referendum we can disentangle the evidence and judge the effects on health and care, says Richard Vize.
Fears extra expense and paperwork caused by Brexit will make Britain unattractive to global drugmakers.
Lord Empey slams 'headlong emotional rush' into Brexit 'without any thought to the detail'
24/01/2023
Sir Reg Empey says he expects a hearing into how the NI Protocol is affecting medicine supplies on Wednesday to bring “more bad news”.
Britain must work with other countries to prevent friction on medicine rules post-Brexit to avoid being sidelined by the global drug industry, according to a report from the U.K.’s biggest pharmaceutical lobby group.
Nuffield Trust: Slow decisions and vague trade slogans leave NHS uncertain of post-Brexit future
20/12/2021
Our report published today looks at six key areas of health and social care that are being impacted by Brexit.
Warning that Brexit red tape could led to vital drugs for epilepsy and cancer being withdrawn in Northern Ireland
20/04/2021
BREXIT red tape is leading to the withdrawal of vital drugs from Northern Ireland due to the high costs for manufacturers, an industry chief has warned.